期刊文献+

肝癌Huh7干细胞样细胞的富集培养及鉴定 被引量:2

Culture and identification of liver cancer stem cell-like Huh7 cells
下载PDF
导出
摘要 目的:建立一种体外有效富集、培养和鉴定具有肝癌于细胞特征的细胞亚群的方法。方法:采用成球培养法利用肿瘤干细胞样细胞(cancerstemcell,CSC)分化培养基对肝癌Huh7细胞进行富集培养,获得的干细胞样细胞于体外进一步扩增获得肝癌干细胞球。流式细胞术检On,0Huh7干细胞样细胞表面肿瘤干细胞标志物EpCAM、CD90和CDl33的表达,平板克隆集落形成实验和裸鼠成瘤实验分别检测Huh7细胞和Huh7干细胞样细胞的克隆集落形成能力、体内成瘤能力。结果:Huh7细胞成球培养3~7d后即可形成肝癌干细胞样细胞球,获得的干细胞样细胞具有自我更新和增殖能力,其EpCAM阳性细胞比例较Huh7细胞明显增加[(99.6%±0.31)%猫(0.12%±O.05)%,P〈0.01],但两种细胞CD90[(0.11%±0.06)%US(0.09%±0.07)%,P〉0.05]和CDl33[(0.17%±0.08)%椰(0.15%±0.05)%,P〉0.05l表达差异无统计学意义。Huh7干细胞样细胞克隆集落形成数量明显多于Huh7细胞[(188.67±12.5)协(79±16.7)个,P〈0.01];当接种量为5X10^4个细胞时,与接种Huh7细胞的对照裸鼠相比,接种Huh'/干细胞样细胞的裸鼠成瘤时间更短(1I”s30d),成瘤率更高(100%郴16.67%);接种5×10’数量级的细胞时,实验组成瘤体积[(171.90±10.94)伽(86.39±11.21)mm^3P〈0.01]和瘤体质量[(2.984±0.82)vs(0.324±0.17)g,P〈0.01]均明显大于对照组。结论:利用成球培养法能够从Huh7肝癌细胞系中富集培养获得Huh7肝癌干细胞,其具有比Huh7细胞更强的成瘤能力。 Objective : To build a method for enrichment, culture and identification of a cell subset which has the char acteristics of liver cancer stem cells (CSC) in vivo. Methods: Huh7 liver cancer cells were subjected to enrichment cul ture in spheric culture condition with cancer stem cell enrichment medium to obtain liver cancer stem cell-like cells. The stem cell-like cells were continuously cultured and proliferated to form liver cancer stem cell sphere in vitro. Flow cytome try assay was performed to detect the expression of the bio-marker moleculars of CSC such as EpCAM ( also named CD326), CD90 and CD133. Colony formation assay and tumorigenicity experiments in nude mice were used to detect the colony formation abilities and tumorigenicity of Huh7 cells and Huh7 stem cell-like cells, respectively. Results : After en richment culture for 3-7 days, Huh7 cells formed cell spheres. The liver cancer stem cell-like sphere-forming cells exhibi ted self-renewal ability and multiplication capacity. The proportion of EpCAM positive cells was significantly increasedcompared to Huh7 cells ( [ 99.6% ±0.31 ] % vs [ 0.12% ± 0.05 ] %, P 〈 0.01 ). However, there is no significant differ- ence in the expression of CD90 ([0.11% _+0.06]% vs [0.09% ±0.07] ,P〉0.05) and CD 133 ([0.17% ±0.081% vs [0.15% ±0.05] ,P 〉0.05) between the I-Iuh7 ceils and sphere-forming ceils. The number of colonies formed by en riched sphere-forming cells was significantly more than that formed by Huh7 cells ( [ 188.67 ± 12.5 vs [ 79 ± 16.7 ], P 〈 0.01 ). Compared with the nude mice inoculation of Huh7 ceils in the control group, tumor-forming time of nude mice noc ulation of Huh7 stem cell-like cells in the experimental group was obviously shorter ( 11 vs 30 d), and showed a higher ra tio of tumor formation( 100% vs 16.67% ) when all the mice of two groups were seeded with 5 x 104 cells. Both tumor vol ume ([171.90±10.94] vs [86.39±11.21] mm3, P〈0.01) and weight ([2.98±0.82] vs [0.32±0.17]g, P〈 0. 01 ) of nude mice in the experimental group was respectively bigger and heavier than that of the control group when the seeding cell number was 5 ~ 105 ceils. Conclusion: Liver cancer stem cell-like ceils could be enriched and transformed from Huh7 ceils with sphere-forming culture method in vitro, and these cells have more powerful tumorigenicity than Huh7 cells do.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2013年第6期690-695,共6页 Chinese Journal of Cancer Biotherapy
基金 国家自然科学基金资助项目(No.81101634) 四川省科技厅基金资助项目(No.2012SZ0058) 四川省卫生厅科研课题资助项目(No.110472 110478) 成都军区医药科技"十二五"重点课题资助项目(No.B12018)~~
关键词 肝癌 肿瘤干细胞样细胞 Huh7细胞系 富集 培养 hepatocellar carcinoma caner stem cell-like cells Huh7 cell line enrichment cuhure
  • 相关文献

参考文献19

  • 1Valent P, Bonnet D, De Maria R, et al.Cancer stem cell defini-tions and terminology:The devil is in the details[J].Nat RevCancer, 2012,12(11):767-775.
  • 2Brabletz T.EMT and MET in metastasis:Where are the cancerstem cells?[J].Cancer Cell,2012, 22(6):699-701.
  • 3Piao LS,Hur W, Kim TK, et al.CD133(+)liver cancer stemcells modulate radioresistance in human hepatocellular carcinoma[J].Cancer Lett, 2012, 315(2):129-137.
  • 4Shekhani MT, Jayanthy AS, Maddodi N et al.Cancer stem cellsand tumor transdifferentiation:Implications for novel therapeuticstrategies[J]. Am J Stem Cells,2013 ,2(1):52-61.
  • 5Yamashita T, Wang XW.Cancer stem cells in the development ofliver cancer[J].J Clin Invest,2013,123(5):1911-1918.
  • 6Singh SR.Gastric cancer stem cells:A novel therapeutic target[J].Cancer Lett, 2013, 338(1):110-119.
  • 7Chiba T, Kita K, Zheng YW et al.Side population purified fromhepatocellular carcinoma cells harbors cancer stem cell-like proper-ties[J].Hepatology, 2006,44(1):240-251.
  • 8Curley MD, Therrien VA, Cummings CL et al.CD133 expressiondefines a tumor initiating cell popululation in primary human ovari-an cancer[J].Stem Cells, 2009, 27(12); 2875-2883.
  • 9Terris B, Cavard C, Perret C.EpCAM, a new marker for cancerstem cells in hepatocellular carcinoma[J].J Hepatol, 2010,52(2):280-281.
  • 10Chen Y, Yu D, Zhang H, et al.CD133(+)EpCAM(+)pheno-type possesses more characteristics of tumor initiating cells in hepa-tocellular carcinoma Huh7 cells[J].Int J Biol Sci,2012 , 8(7):992-1004.

二级参考文献77

  • 1倪晓光,赵平.实体瘤肿瘤干细胞的研究进展[J].癌症,2006,25(6):775-778. 被引量:6
  • 2Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells [J]. Nature, 2001,414 (6859) : 105-111.
  • 3Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer [J]. Nat Rev Cancer, 2003,3 ( 12 ) : 895-902.
  • 4Bergsagel DE, Valeriote FA. Growth characteristics of a mouse plasma celltumor [J]. Cancer Res, 1968,28 (11) :2187-2196.
  • 5Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice [J]. Nature, 1994, 367 ( 6464 ) : 645-648.
  • 6Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell [J]. Nat Med, 1997,3 (7) : 730-737.
  • 7Al-Hajj M, Wicha MS, Benito- Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells [J]. Proc Natl Acad Sci USA, 2003,100(7) :3983-3988.
  • 8Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors [J]. Cancer Res, 2003,63(18) :5821-5828.
  • 9Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating ceils [J]. Nature, 2004,432 (7015) : 396-401.
  • 10Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bronchioalveolar stem ceils in normal lung and lung cancer [J]. Cell, 2005,121 (6) :823-835.

共引文献6

同被引文献6

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部